The rise of nanometers

Huang Xiuyuan at the Shanmei headquarters read the recent work reports. Mo Siqian, who returned from a business trip in Quancheng, reported to him the clinical testing status of swine fever vaccine, photothermal knife, and gold inhibitors.

"Chairman, in the current third phase of testing of the swine fever vaccine, a total of 156,974 pigs have been injected. The test results are very good, and only 8 pigs died."

Huang Xiuyuan read the swine fever vaccine test report and found that the eight pigs that died were mainly due to the presence of other diseases in their bodies and their inability to adapt to the vaccine. This is also normal.

"Yes, as a veterinary vaccine, the mortality rate is already very good."

Mo Siqian naturally understood.

Zhao Xiaojun on the side said with a smile: "Major breeding companies across the country are already ready to take action, especially those on the northeast and southeast coast. They have repeatedly asked when the vaccine will be available."

"Clinical testing cannot be sloppy. The third phase of testing will not be obtained until at least October this year before the marketing license is obtained." Mo Siqian spread his hands helplessly.

Huang Xiuyuan was also not too anxious: "Don't worry, safety is the most important thing. I rejected those companies that wanted to use clinical quotas to inject in advance. The vaccine is not Radix isatidis."

As one of the veterans of the Suiren family, Zhao Xiaojun naturally understands that the giant Suiren family needs to be more careful to a certain extent.

Many companies and bosses in China have dirty butts when they make a fortune. If flies don't bite seamless eggs, they will repeatedly jump on the bottom line, and sooner or later they will stumble.

Many of the technologies and strategies promoted by Huang Xiuyuan have actually been discussed with the above, and they have official endorsement.

As for the Phase III clinical scale of the swine fever vaccine, the limited number is 200,000 animals. There is no need for Shennong Group to do side projects just for that little money.

After reporting on the swine fever vaccine, Mo Siqian also talked about the testing of the near-infrared photothermal knife:

"Chairman, judging from the current feedback from Qilu Hospital, the patient's recovery is very good. According to the evaluation of Chang Zhiwen, director of the oncology department of the hospital, the results are in line with our expectations."

Huang Xiuyuan looked at the details.

According to the comprehensive assessment of Shennong Group, the 10-year survival rate of early- and mid-stage patients may be close to 100%.

As for late-stage patients, it depends on the situation. This is closely related to the type and location of the cancer, and whether the patient has other underlying diseases.

If complications such as organ failure, organ necrosis, brain compression, or cerebral hemorrhage have already occurred, even if the cancer cells are removed, there may be no way to recover.

Huang Xiuyuan saw this and ordered: "You should cooperate more with Feipeng and use shared medical care and mobile medical fleets to increase the physical examination of domestic people so that patients can be detected and treated early."

Zhao Xiaojun understood some internal information: "In this regard, the Ministry of Health is actually very supportive. I heard that Feipeng has planned to increase the scale of shared medical care and mobile medical fleets this year, striving to cover all parts of the country."

Supporting shared medical examinations and mobile medical fleets is actually to relieve the pressure on medical insurance. Many people often do not pay attention to physical examinations, causing minor illnesses to become serious illnesses.

The amount of medical insurance reimbursed for a critical illness often starts in the tens of thousands, which invisibly increases the burden on the medical insurance fund.

Through early detection and early treatment, curbing the proportion of severe cases has become an effective means to reduce the pressure on medical insurance.

With near-infrared light photothermal knife therapy, an early-stage patient only needs a few thousand yuan, while a late-stage patient starts at 30,000 yuan, and this is the cost of treatment after reimbursement.

It can be seen from this that the difference between severe and mild symptoms is huge.

This not only puts financial pressure on medical insurance, but also increases the financial burden on patients.

Under such circumstances, the Ministry of Health naturally supports Feipeng Group's shared medical project. Especially with the maturity of photothermal knife technology, the cancer cure rate has increased significantly, while the cost of treatment has dropped by an order of magnitude. It is even more important to increase Shared medical care.

After talking about the photothermal knife and shared medical care, Mo Siqian talked about the situation of gold inhibitors:

"Chairman, gold inhibitors are indeed better than ordinary inhibitors for CCR5 type AIDS patients. They can also be used in cocktail therapy, but the price is relatively high."

"There is no way around it. Our R\u0026D expenses, plus the price of gold itself, are 5,000 yuan per course of treatment. Our profit is not high." Zhao Xiaojun shrugged.

In fact, Shennong Group has no plans to promote gold inhibitors in the near future. Although a course of treatment costs 5,000 yuan and the net profit is about 3,000 yuan, as a palliative drug, its market competitiveness is not high.

Only a small number of patients can afford gold inhibitors with such a high price, and the cost is there.

Although photothermal knife therapy also requires gold nanorod particles, gold nanorods are a one-time radical treatment, and most of the gold in the patient's body will be excreted within half a month.

With Suiren's recycling technology, this gold will be reused.

During the use of gold inhibitors, patients cannot always be hospitalized, and it is difficult to recover gold efficiently.

Although the amount of gold refined by the Suiren Sect each year reaches about 150 to 200 tons, more than half of this is purchased by the central bank, and the Suiren Sect itself consumes a lot of gold in industry.

Therefore, the current price of gold inhibitors is destined to remain high.

Perhaps when the technology of the cell trap method matures, it can be put into the market on a large scale.

Huang Xiuyuan didn't have many options: "That's all we can do for the time being."

Mo Siqian suddenly remembered something and reported a situation to him:

"Chairman, one more thing. The editor-in-chief of The Lancet magazine sent us an invitation letter, hoping that the research and development team of photothermal knife technology can go to London to give an academic lecture."

Huang Xiuyuan shook his head: "The Lancet is going to hold an academic exchange meeting? Even if it is held, we will hold it in China. It is a basic requirement that core technical personnel do not leave the country. If there are similar invitations in the future, we will directly reject it."

"I understand." Mo Siqian nodded. Although he had also studied abroad, it did not mean that he blindly agreed with the West.

The current international situation seems to be calm, but in fact there is an undercurrent. The Suiren Department, which is in the eye of the storm, has been reminding all employees not to leave the country without permission through its internal publicity and training.

When something happens abroad, or someone jumps at you, it is sometimes difficult to react in time at home.

Speaking of invitations for overseas academic exchanges, Zhao Xiaojun asked casually: "Chairman, many foreign companies have recently sent cooperation consultation letters, but not many of them are sincere cooperation companies."

"The price is right and the equipment can be exported abroad. Anyway, the core technology of the photothermal knife is gold nanorods and targeting compounds. They can only purchase it from us." Huang Xiuyuan did not refuse blindly.

There are also foreign scientific research institutions studying similar technologies, but the problems they encounter are that the cost of gold nanorods is too high and they are unable to create gold nanorods with special structures.

This small gold nanorod must possess the resonance effect of near-infrared light, thermal conductivity, high-speed photothermal conversion rate, overload decomposition, and weak binding force to targeting compounds.

The technical content is very high, and only the Suiren series with advanced nanotechnology can produce large-scale, low-cost products.

If other companies want to imitate, they need to at least upgrade a series of nanotechnology to have the foundation for R\u0026D and production.

Thank you for your support (ω｀).

I have a cold????, it’s so uncomfortable